To substantiate our bioinformatical analyses, we prioritize clinically relevant (and biochemically active) kinases using a novel computational pipeline to set the threshold for a kinome screen conducted on STAT3-perturbed GBM cells. This evidence concerns the gene STAT3 and glioblastoma.